PT1049672E - Derivados de azetidinocarboxamida para o tratamento de disturbios do snc - Google Patents

Derivados de azetidinocarboxamida para o tratamento de disturbios do snc

Info

Publication number
PT1049672E
PT1049672E PT99902658T PT99902658T PT1049672E PT 1049672 E PT1049672 E PT 1049672E PT 99902658 T PT99902658 T PT 99902658T PT 99902658 T PT99902658 T PT 99902658T PT 1049672 E PT1049672 E PT 1049672E
Authority
PT
Portugal
Prior art keywords
treatment
disorders
azetidinocarboxamide
snc
derivatives
Prior art date
Application number
PT99902658T
Other languages
English (en)
Portuguese (pt)
Inventor
David Reginald Adams
Corinna Dagmar Bodkin
Nathaniel Julius Monck
Robin Gerald Shepherd
Ian Anthony Cliffe
Howard Langham Mansell
Original Assignee
Vernalis Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801500.1A external-priority patent/GB9801500D0/en
Priority claimed from GBGB9824457.7A external-priority patent/GB9824457D0/en
Application filed by Vernalis Res Ltd filed Critical Vernalis Res Ltd
Publication of PT1049672E publication Critical patent/PT1049672E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT99902658T 1998-01-23 1999-01-22 Derivados de azetidinocarboxamida para o tratamento de disturbios do snc PT1049672E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801500.1A GB9801500D0 (en) 1998-01-23 1998-01-23 Chemical compounds - II
GBGB9824457.7A GB9824457D0 (en) 1998-11-06 1998-11-06 Chemical compounds II

Publications (1)

Publication Number Publication Date
PT1049672E true PT1049672E (pt) 2004-02-27

Family

ID=26313010

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99902658T PT1049672E (pt) 1998-01-23 1999-01-22 Derivados de azetidinocarboxamida para o tratamento de disturbios do snc

Country Status (10)

Country Link
US (1) US6403574B1 (enExample)
EP (1) EP1049672B1 (enExample)
JP (1) JP4542263B2 (enExample)
AT (1) ATE250027T1 (enExample)
AU (1) AU2287499A (enExample)
DE (1) DE69911373T2 (enExample)
DK (1) DK1049672T3 (enExample)
ES (1) ES2207171T3 (enExample)
PT (1) PT1049672E (enExample)
WO (1) WO1999037612A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917386D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-II
AU2004234125A1 (en) * 2003-05-01 2004-11-11 Vernalis Research Limited Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
US20060276452A1 (en) * 2003-05-01 2006-12-07 Vernalis Research Limited Use of azetidinecarboxamide derivatives in therapy
EP1618105A1 (en) * 2003-05-01 2006-01-25 Vernalis Research Limited Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
US11141404B1 (en) * 2020-11-18 2021-10-12 Anebulo Pharmaceuticals, Inc. Formulations and methods for treating acute cannabinoid overdose
US11795146B2 (en) 2021-10-11 2023-10-24 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872447A (en) 1958-12-23 1961-07-12 Lepetit Spa 1-carbamyl-3-substituted azetidines
US4226861A (en) 1978-04-18 1980-10-07 A. H. Robins Company, Inc. N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
IL68699A (en) * 1982-08-19 1986-08-31 Robins Co Inc A H 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
US4505907A (en) 1982-09-02 1985-03-19 A. H. Robins Company, Inc. N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
IE58943B1 (en) * 1985-02-28 1993-12-01 Robins Co Inc A H 3-Aryloxy-azetidine-carboxamides
US4956359A (en) * 1985-02-28 1990-09-11 A. H. Robins Company, Inc. 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics

Also Published As

Publication number Publication date
JP4542263B2 (ja) 2010-09-08
DE69911373D1 (de) 2003-10-23
DK1049672T3 (da) 2004-01-19
ES2207171T3 (es) 2004-05-16
EP1049672A1 (en) 2000-11-08
WO1999037612A1 (en) 1999-07-29
ATE250027T1 (de) 2003-10-15
AU2287499A (en) 1999-08-09
US6403574B1 (en) 2002-06-11
JP2002501045A (ja) 2002-01-15
DE69911373T2 (de) 2004-07-01
EP1049672B1 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
GB9801690D0 (en) Therapeutic agents
PH31123A (en) Benzimidazole compounds.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
AP2002002637A0 (en) Novel piperazine
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
NZ331452A (en) use of 2-(4-indolyl-1-piperazinyl)alkylene-N-(2-pyridyl)-cyclohexane- carboxamide derivatives in treating central nervous system disorders
GB0018272D0 (en) Chemical compounds IV
SE0104334D0 (sv) Therapeutic agents
FI931765A0 (fi) Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar
PL341514A1 (en) Substituted compounds of 2-benzylamino-2-phenyl acetamide
SI1000034T1 (en) Substituted 6-alkylphenanthridines
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
MY129292A (en) Antivirals
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
AU640590B2 (en) 3-(1h-indazol-3-yl)-4-pyridinamines
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
AP2002002595A0 (en) Heterocyclic amide derivatives.
MY136138A (en) Hexacyclic compounds
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus